NUPREVIQ
Live / Registered — Registered — Section 71 accepted (as of 04 Feb 2026)
What this means for you
Registered since 22 Dec 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79169811
- Registration number
- 4872533
- Mark type
- Stylized text
- Filed
- 15 May 2015
- Published for opposition
- 06 Oct 2015
- Registered
- 22 Dec 2015
- Attorney of record
- Henry B. Ward, III
Goods and services
- Class 044 — Medical, beauty and agricultural services: Medical testing of patients for determining individual risk of forming inhibitors during a hemophilia treatment with factor VIII
Owner
- Octapharma AG, Lachen, CH
- Octapharma AG, CH
- Octapharma AG, CH
Prosecution history
- 04 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 04 Feb 2026 — REGISTERED-SEC.71 ACCEPTED
- 26 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Sept 2025 — TEAS SECTION 71 RECEIVED
- 29 May 2025 — INTERNATIONAL REGISTRATION RENEWED
- 22 Dec 2024 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 05 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Jul 2022 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 11 Jul 2022 — REGISTERED-SEC.71 ACCEPTED
- 06 Jun 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Dec 2021 — TEAS SECTION 71 RECEIVED
- 19 Aug 2016 — NOTIFICATION PROCESSED BY IB
- 18 Aug 2016 — NEW REPRESENTATIVE AT IB RECEIVED